Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Northwest's prostate cancer vaccine shows favorable progress in clinical trial

Oct. 2, 2000

3-D researchers patent alphav integrin inhibitors with broad indications

Sep. 29, 2000

Two-antigen combination melanoma vaccine enters phase I/II at MGH

Sep. 29, 2000

Results of marimastat/carboplatin combination trial in ovarian cancer disappointing

Sep. 29, 2000

New prostate cancer vaccine selected for clinical trials by Progenics, Cytogen

Sep. 29, 2000

Stable and safe antineoplastic agents developed at Ohio State University

Sep. 28, 2000

Series of cdk inhibitors described in Pharmacia patent

Sep. 28, 2000

Encouraging antitumor activity reported for IGT Pharma's AVLB

Sep. 28, 2000

Ilex Oncology's first angiogenesis inhibitor enters phase I in France

Sep. 28, 2000

Topical formulation of Targretin launched in U.S. for CTCL therapy

Sep. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...